Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
5.17
-0.18 (-3.36%)
Mar 3, 2026, 4:00 PM EST - Market closed
Perspective Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Perspective Therapeutics stock have an average target of 12.2, with a low estimate of 7.00 and a high estimate of 16. The average target predicts an increase of 135.98% from the current stock price of 5.17.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Buy | 5 | 5 | 3 | 3 | 3 | 4 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 10 | 10 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $16 | Buy | Initiates | $16 | +209.48% | Feb 19, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +132.11% | Jan 30, 2026 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +112.77% | Jan 30, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +170.79% | Jan 13, 2026 |
| Truist Securities | Truist Securities | Strong Buy Initiates $8 → $12 | Strong Buy | Initiates | $8 → $12 | +132.11% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
1.09M
from 1.45M
Decreased by -25.38%
Revenue Next Year
996.34K
from 1.09M
Decreased by -8.17%
EPS This Year
-1.27
from -1.23
EPS Next Year
-1.28
from -1.27
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.4M | 1.5M | ||||
| Avg | 1.1M | 996,336 | ||||
| Low | 824,180 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.4% | 35.5% | ||||
| Avg | -25.4% | -8.2% | ||||
| Low | -43.3% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.16 | -1.04 | ||||
| Avg | -1.27 | -1.28 | ||||
| Low | -1.30 | -1.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.